# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UBS analyst Kevin Caliendo maintains Labcorp Hldgs (NYSE:LH) with a Buy and raises the price target from $305 to $325.
Mizuho analyst Ann Hynes maintains Labcorp Hldgs (NYSE:LH) with a Outperform and raises the price target from $285 to $320.
Evercore ISI Group analyst Elizabeth Anderson maintains Labcorp Hldgs (NYSE:LH) with a Outperform and raises the price targe...
Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, announced today a collaboration with Ro...